2 1 Shi Ji Jing Ji Bao Dao·2025-08-29 11:20Core Viewpoint - Alibaba Health and LEO Pharma have announced a strategic partnership to enhance digital health management and improve accessibility to innovative treatments for skin diseases [1][4]. Group 1: Strategic Partnership - The collaboration focuses on technology-driven medical innovation, comprehensive health management, and improving the accessibility of innovative drugs [1]. - Alibaba Health has a user base of 300 million and has partnered with thousands of pharmaceutical companies globally [3]. - LEO Pharma has been active in China, promoting awareness and standardized treatment for skin diseases like psoriasis and atopic dermatitis, helping over 65 million patients [3]. Group 2: Digital Health Management - The partnership aims to deepen the patient-centered digital health management model, integrating LEO's innovative drugs with Alibaba's digital capabilities [4]. - Previous joint projects have shown significant results, with patient medication adherence increasing by 30% and up to 3.2 times for those in chronic disease community management [3]. - The collaboration will continue to explore scientific management in post-diagnosis home settings, providing smarter, personalized, and efficient health management solutions [5].